Comorbid Symptoms of Emotional Distress in Adult Survivors of Childhood Cancer
Overview
Authors
Affiliations
Background: Childhood cancer survivors are at risk for emotional distress symptoms, but symptom comorbidity has not been previously examined. This study examined distress profiles for adult survivors of childhood cancer diagnosed between 1970 and 1999.
Methods: Self-reported depression, anxiety, and somatization symptoms from Brief Symptom Inventory 18 were examined in survivors (n = 16,079) and siblings (n = 3085) from the Childhood Cancer Survivor Study. A latent profile analysis identified clusters of survivors with individual and comorbid symptoms. Disease, treatment, and demographic predictors of distress comorbidity patterns were examined with multinomial logistic regressions.
Results: Four clinically relevant profiles were identified: low distress on all subscales (asymptomatic, 62%), high distress on all subscales (comorbid distress, 11%), elevated somatization (somatic symptoms, 13%), and elevated depression and anxiety (affective distress, 14%). Compared with siblings, fewer survivors were asymptomatic (62% vs 74%, P < .0001), and more had comorbid distress (11% vs 5%, P < .0001). Survivors of leukemia (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.12-1.61), central nervous system tumors (OR, 1.30; 95% CI, 1.05-1.61), and sarcoma (OR, 1.26; 95% CI, 1.01-1.57) had a greater risk of comorbid distress than survivors of solid tumors. Psychoactive medications were associated with comorbid distress (P < .0001), and this suggested that this group was refractory to traditional medical management. Comorbid distress was associated with poor perceived health (OR, 31.7; 95% CI, 23.1-43.3), headaches (OR, 3.2; 95% CI, 2.8-3.7), and bodily pain (OR, 4.0; 95% CI, 3.2-5.0).
Conclusions: A significant proportion of survivors are at risk for comorbid distress, which may require extensive treatment approaches beyond those used for individual symptoms. Cancer 2016;122:3215-24. © 2016 American Cancer Society.
Noyd D, Izurieta-Pacheco A, Mzikamanda R, Nakiddu N, An D, Souvanlasy B JCO Glob Oncol. 2025; 11:e2400274.
PMID: 39946668 PMC: 11892615. DOI: 10.1200/GO-24-00274.
Pain and Frailty in Childhood Cancer Survivors: A Narrative Review.
Papini C, Sodhi J, Argenbright C, Ness K, Brinkman T Curr Oncol. 2025; 32(1).
PMID: 39851938 PMC: 11763768. DOI: 10.3390/curroncol32010022.
Deng W, Lie H, Ruud E, Loge J, Kiserud C, Rueegg C Cancer Med. 2024; 13(22):e70425.
PMID: 39584526 PMC: 11586778. DOI: 10.1002/cam4.70425.
Profile of Sensory Integration Disorders in Migraine Patients-New Perspectives of Therapy.
Kaniewska A, Baginska E, Masztalewicz M, Mross K, Jankowska M, Nowacki P J Clin Med. 2024; 13(13).
PMID: 38999493 PMC: 11242493. DOI: 10.3390/jcm13133928.
Psychological outcomes in patients with rare cancers: a systematic review and meta-analysis.
Low C, Loke S, Pang G, Sim B, Yang V EClinicalMedicine. 2024; 72:102631.
PMID: 38726223 PMC: 11079476. DOI: 10.1016/j.eclinm.2024.102631.